AVENTURA, Fla., May 31, 2018 /PRNewswire-PRWeb/ -- Specialty Med Training and PRP Science, leading companies
In the last five (5) years, interest in PRP has exponentially soared, and consumer demand is driving the majority of its popularity. Recent reports show over 60% of Americans age 50+ are pursuing regenerative interventions, with PRP therapies and non-surgical treatment options topping the list.
PRP is derived from harvesting and concentrating a patient's own blood. Since it is an autologous biologic - derived from the patient's own blood - its potential to provide a treatment option with a near perfect safety and efficacy profile is unmatched by any drug or surgical procedure. Unfortunately, because it does not require FDA approval, this leaves little room for regulation by the governing medical establishments and has hindered the development of "Standard of Care" guidelines. For this reason, confusion is also soaring, for both the consumer and the clinician.
This unique "Call for Standards" is a result of the confusion in the marketplace. The fact is, not all PRP is equal. Many of the devices being used today to satisfy consumer demands do not even meet the scientific definition of "Platelet Rich Plasma." In spite of their claims, many are not capable of consistently processing and producing PRP with the necessary cellular components to achieve tissue healing and regeneration.
The expert panel will peel back the layers of confusion and controversary surrounding the use of PRP and arm interested attendees with the expert knowledge necessary to make the best business and clinical decisions for anyone deciding to add these treatment options to their practice offering.
The panelist line-up includes: Peter A. Everts, PhD, known as the "Father of PRP, has dedicated his career to the research, specifically the scientific study of autologous biologics. Joseph Banno, MD, board certified urologist, who in over the 30+ years of treating sexual dysfunction in men and women, developed a combined treatment protocol utilizing PRP, shockwave and hormone therapy that has had overwhelming success as a surgical alternative. Lisa Vuich, MD, anti-aging and regenerative expert and founder of Renew MediSpa in Windham, NH. Dr. Vuich is a member of the Bridging Biosciences advisory board which has developed a trademarked protocol designed to deliver proven therapeutic concentrations of platelets with customized dosing of individual PRP therapy.
The panelists are recognized by their peers as true pioneers - leading the path towards evidence-based medicine and committed to educating practitioners on the science surrounding PRP's healing potential - while promoting an ethical and responsible approach to new applications harnessing the power of PRP.
Whether you have been using PRP for many years or are new to the experience, it's important to stay current with the scientific literature that is helping us define and explore the efficacy of PRP and other regenerative treatments.
Entrance fee is $20 and proceeds go towards continued research and the continued study of regenerative therapies utilizing PRP.
Online registration is required and space is limited to the first 25 registrants. Registrants must be practitioners in clinical practice. No selling of any kind will take place during this event.
Specialty MED Training offers hands on 1 and 2-day regenerative combination therapy courses led by a team of board certified medical experts. Physicians work side by side learning advanced scientific techniques utilizing platelet rich plasma, shockwave therapy, imaging and aesthetic applications to enhance providers' medical skill and injection techniques. Follow Specialty MED Training on Facebook and YouTube.
PRP Science helps physicians provide advanced treatment options using state-of-the art science, devices and medical equipment that are revolutionizing the regenerative medicine industry. Follow PRP Science on Facebook and YouTube.
SOURCE Specialty Med Training
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All